Dr. Thomson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1152 E 200 N
American Fork, UT 84003Phone+1 801-772-0698Fax+1 801-772-0705
Summary
- I am a physician, board certified in Medical Oncology, Hematology, and Internal Medicine. I have a wide array of clinical interests: from breast cancer to malignant hematology, melanoma, lung and GI cancers, and benign hematology.
Education & Training
- University of TennesseeFellowship, Hematology and Medical Oncology, 2018 - 2021
- University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2014 - 2017
- University of Arizona College of MedicineClass of 2014
- Brigham Young UniversityBS, Biophysics; Minor in Chemistry, 2006 - 2010
Certifications & Licensure
- MT State Medical License 2022 - 2026
- UT State Medical License 2020 - 2026
- TN State Medical License 2018 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsHigh GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.Anngela C Adams, Elizabeth S Borden, Anne M Macy, Nick Thomson, Haiyan Cui
Cancers. 2022-04-28 - The Pulmonary Complications of Paraneoplastic Autoimmune Vasculitis in a Patient With Myelodysplastic Syndrome.Pooja S. Jagadish, Anna-Carson Rimer Uhelski, Jordan Redfield, Nicholas Thomson, Osarenren Ogbeide
Cureus. 2020-07-19 - 5 citationsMaintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature.Nick Thomson, Matthew L. Ulrickson
Clinical Case Reports. 2016-07-06
Journal Articles
- Adjuvant Therapy in Resected Melanoma, Letter to the Editor.Nick Thomson, MD, Rachel Doerr, NP, Michael G. Martin, MD, New England Journal of Medicine, 2018 Feb; 378(7):678-80.
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: